Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Maintenance of the ES Cell State

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritis.

Immunotherapy advances·2025

Same author

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.

Immunity·2024

Same author

The Role of ICL1 and H8 in Class B1 GPCRs; Implications for Receptor Activation.

Frontiers in endocrinology·2022

Same author

Regulatory T cells and transplantation tolerance: Emerging from the darkness?

European journal of immunology·2021

Same author

Haplobanking induced pluripotent stem cells for clinical use.

Stem cell research·2020

Same author

Infectious tolerance. What are we missing?

Cellular immunology·2020

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

Embryonic stem cells: protecting pluripotency from alloreactivity.

Paul J Fairchild¹, Nathan J Robertson, Stephen L Minger

¹University of Oxford, Sir William Dunn School of Pathology, South Parks Road, Oxford OX1 3RE, UK. Paul.Fairchild@path.ox.ac.uk

Current Opinion in Immunology

|August 22, 2007

Summary

2006 was a difficult year for therapeutic cloning using somatic nuclear transfer (SNT). Due to fraud in patient-specific embryonic stem (ES) cell generation, cell replacement therapies (CRT) face challenges. Alternative immune evasion strategies may be needed.

More Related Videos

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Related Experiment Videos

Last Updated: Jul 13, 2026

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Area of Science:

Stem cell biology
Regenerative medicine
Bioethics

Background:

Somatic nuclear transfer (SNT) aimed to create patient-specific embryonic stem (ES) cell lines for cell replacement therapies (CRT).
The year 2006 saw significant setbacks due to fraudulent SNT research, impacting the field of therapeutic cloning.
This fraud raised concerns about the feasibility and ethical implications of SNT-derived therapies, particularly regarding immune rejection.

Purpose of the Study:

To evaluate the impact of the 2006 SNT fraud on the future of therapeutic cloning.
To reassess the viability of somatic nuclear transfer (SNT) for generating patient-specific stem cells.
To explore alternative strategies for immune evasion in the context of cell replacement therapies (CRT).

Main Methods:

Review of scientific literature and ethical considerations surrounding therapeutic cloning.
Analysis of the consequences of fraudulent research in stem cell generation.
Exploration of alternative approaches to overcome immune rejection in regenerative medicine.

Main Results:

The 2006 SNT fraud significantly damaged the credibility and progress of therapeutic cloning.
Hopes for immune-rejection-free cell replacement therapies (CRT) were diminished.
The need for alternative strategies to achieve immune tolerance in regenerative medicine became evident.

Conclusions:

The promise of somatic nuclear transfer (SNT) for therapeutic cloning is questioned following the 2006 scandal.
Alternative methods for immune evasion are crucial for advancing cell replacement therapies (CRT).
Further research is needed to determine the future viability of SNT or to develop robust alternative strategies.